Consumers do pay attention to DTC ads for prescription drugs. A study by the Pew Research Center found that 72% of adults have seen a DTC ad for a prescription drug in the past year. Of those who have visited a DTC ad, 57% said that the ad made them more likely to ask their doctor about the drug.
(Stat News) An array of cancers — colorectal chief among them — are striking people younger than 50 at higher rates than in previous decades, prompting new screening guidelines, new research, and growing concern.
The United States is the wealthiest nation in the world but is also one of the unhealthiest. Americans have shorter life expectancies and higher rates of chronic diseases than people in other developed countries.
The nation’s monthslong shortage of highly potent cancer drugs is grinding on, forcing patients and their doctors to face even grimmer realities than that cancer typically presents. Several factors have contributed to the shortage of cancer drugs, and patients are hurting. What’s going on? At the heart of the problem is that US pharma companies have zero interest in manufacturing off-patent cancer drugs. They have sold the rights to foreign companies whose quality control is a huge issue. Here are the other issues.
There is evidence that blood thinners may be overly prescribed in some cases. A study published in the journal JAMA Internal Medicine in 2017 found that the rate of blood thinner prescriptions increased by 50% between 2000 and 2014. This increase was not seen in all age groups and was most pronounced in people over 65.
Direct-to-consumer (DTC) prescription drug advertising is a controversial topic. Some people believe it helps patients become more informed about their treatment options, while others believe it leads to over-prescription and inappropriate use of medications.
Studies have shown that direct-to-consumer (DTC) advertised drugs are more expensive than non-advertised drugs. For example, a study by the Kaiser Family Foundation found that DTC-advertised drugs cost an average of $3.70 more per prescription than non-advertised drugs.
The high cost of healthcare is a major problem in the United States. It is a problem that affects everyone, regardless of their income or health status. We need to find ways to reform the healthcare system so that it is more affordable and efficient, and so that everyone can get the care they need. We spend more on healthcare than any other country in the world, yet it has some of the worst health outcomes. This is a paradox that has been puzzling experts for years.